← Leaderboards
Lloyd G Mitchell
Intronn, Inc.
$4,364,277
Attributed
$4,364,277
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $521.3K · FY2010–15$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,364,277 · 6
By mechanism
R44$2,794,989 · 1
R43$1,569,288 · 5
Top collaborators
No co-investigators on record.
Most similar at Intronn, Inc.
Same institution · by research overlap
- S Gary Mansfield$3,277,846
- Gerard J. Mc Garrity$434,066
- Madaiah Puttaraju$423,763
- Colette Ann Cote$101,474
Others in their field
Top investigators on “Spliceosomes”
- Adrian R Krainer · Cold Spring Harbor Laboratory$22,708,373
- Douglas L. Black · University Of California Los Angeles$14,037,681
- Robin E Reed · Harvard University (Medical School)$13,189,028
- Christine Guthrie · University Of California San Francisco$12,854,186
- Manuel Ares · University Of California Santa Cruz$12,786,537
- Stephen C Harrison · Boston Children'S Hospital$11,770,640
Research focus
SpliceosomesRna SplicingCystic FibrosisGene TherapyGene TargetingPre-ClinicalLaboratory MouseCellsGenesTrans-SplicingGene ExpressionLeadChloride ChannelsMutantSpecificityBasePrecursor MrnaMutationPolymerase Chain ReactionProteinsBiotherapeutic AgentDrug Design /Synthesis /ProductionExonsMessenger Rna
Grant awards (8)
Optimizing correction of the Huntington's disease mutation by trans-splicing$226,921
R43 · FY2015 · NS · contact PI
Correcting Aberrant Splicing of the Human CD22 Gene$225,000
R43 · FY2014 · CA · contact PI
Development of tools to modify globin gene expression in stem cells$521,305
R43 · FY2011 · HL · contact PI
Optimization of a method to reduce expression of progerin, the cause of HGPS (Pro$372,089
R43 · FY2010 · AG · contact PI
Development of SMaRT gene therapy for Cystic Fibrosis$223,973
R43 · FY2003 · DK
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$1,357,285
R44 · FY2001 · DK
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$562,206
R44 · FY2001 · DK
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$875,498
R44 · FY2000 · DK